Are you up-to-date on the latest data in HER2-positive early breast cancer? Join our experts as they discuss the data and the clinical implications!

Credit available for this activity expires: 01/29/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/her2-positive-early-breast-cancer-what-latest-data-mean-your-2026a10002fg?ecd=bdc_podcast_libsyn_mscpedu

How can we optimize ART in people living with HIV while addressing comorbidities and minimizing toxicity?

Credit available for this activity expires: 01/15/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/balancing-art-and-comorbidities-aging-people-living-hiv-2026a1000127?ecd=bdc_podcast_libsyn_mscpedu

Low-carbon inhalers: Are you finding the right balance for optimal patient care and planetary health?

Credit available for this activity expires: 12/31/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/alarming-carbon-footprint-respiratory-disease-future-2025a1000y0k?ecd=bdc_podcast_libsyn_mscpedu

Are you asking about sleep, activity levels, and mood? Why you should be and what to do next.

Credit available for this activity expires: 12/31/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/achieving-brain-health-epilepsy-what-can-clinicians-do-2025a1000y6t?ecd=bdc_podcast_libsyn_mscpedu

Discover the patients who need timely treatment for metabolic dysfunction–associated steatohepatitis (MASH). How will you find them? And then what will you do?

Credit available for this activity expires: [12/30/26] Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/patient-case-challenge-how-would-you-manage-this-patient-2025a1000zqo?ecd=bdc_podcast_libsyn_mscpedu

Alarming in immunoglobulin A nephropathy (IgAN): over 40% present late. Explore latest advancements in management of the most common cause of primary glomerulonephritis worldwide.

Credit available for this activity expires: 12/23/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/navigating-challenges-igan-management-clinical-implications-2025a1000w9b?ecd=bdc_podcast_libsyn_mscpedu

How well are you managing patients on EGFR inhibitor therapies in your clinical practice?

Credit available for this activity expires: 12/18/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/person-centered-care-egfr-mutated-advanced-nsclc-optimizing-2025a1000xxa?ecd=bdc_podcast_libsyn_mscpedu

Learn from the experts about selecting the right BTK inhibitor therapy for patients with chronic lymphocytic leukaemia (CLL) in UK clinical practice.

Credit available for this activity expires: 12/16/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/charting-course-cll-clinicians-compass-btk-inhibitor-therapy-2025a1000yei?ecd=bdc_podcast_libsyn_mscpedu

Did you know that, while well established in the metastatic setting, second-generation antibody-drug conjugates are now moving into the early setting?

Credit available for this activity expires: 12/10/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/how-are-adcs-shaping-future-early-breast-cancer-care-latest-2025a1000yca?ecd=bdc_podcast_libsyn_mscpedu

Join the program for an in-depth discussion on low-grade glioma – from burden and diagnosis to therapies.

Credit available for this activity expires: 12/10/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/pediatric-low-grade-glioma-braf-alterations-stories-science-2025a1000x3w?ecd=bdc_podcast_libsyn_mscpedu